Indian Science and Technology Developments : Updates and Discussions
- Thread starter Gautam
- Start date
Govt spent Rs 180 cr on Zoho-backed email platform; 16.68 lakh official accounts migrated
MeitY said pricing under contract with Zoho ranges from Rs 170 to Rs 300 per account per month for mailbox sizes between 30 GB and 100 GB.
theprint.in
Food for thought:
In spite of buying German TBM machines, India has been at the mercy of China because they're manufactured there.
Iran has built world class TBM tech but their scientists/engineers are currently out of a job.
Should India poach them to jumpstart its TBM industry?
In spite of buying German TBM machines, India has been at the mercy of China because they're manufactured there.
Iran has built world class TBM tech but their scientists/engineers are currently out of a job.
Should India poach them to jumpstart its TBM industry?
Its not that deep! (pun intended).
They saw tunnels as a strategic necessity for their national objectives, such as nuclear and missile developments. West obviously wont help them in this regard. Thus they planned and worked for decades to master it.
YES! but I sadly dont think our babus are smart enough. Thankfully though BEML seems to have started TBM development so we might have indegenous TBMS relatively soon.
the German TBM maker is also expanding production to large scale TBMs in their chennai facility so we will have at least one by end of 2027 and maybe 2 by 2032 ish.
Right thread for this?
timesofindia.indiatimes.com
The US Food & Drug Administration (USFDA) approval of Wockhardt’s Zaynich, a first-in-class "breakthrough antibiotic" for severe drug-resistant infections, opens up a significant global market opportunity and marks a watershed moment for India’s pharmaceutical industry, the company’s founder chairman Habil Khorakiwala told TOI on Monday.
Zaynich, a combination of cefepime and zidebactam, is the first novel drug discovered and developed in India to secure USFDA approval, with peak sales estimated at over $1.5 billion, he said.
====
Indian Pharma companies are moving up the value chain.
'USFDA nod for Zaynich a major boost'
NEW DELIH: The US Food and Drug Administration’s (USFDA) approval of Wockhardt’s Zaynich, a first-in-class ``breakthrough antibiotic'' for severe drug-resistant infections, opens up a significant global market opportunity and marks a watershed moment for India’s pharmaceutical industry, the...
timesofindia.indiatimes.com
The US Food & Drug Administration (USFDA) approval of Wockhardt’s Zaynich, a first-in-class "breakthrough antibiotic" for severe drug-resistant infections, opens up a significant global market opportunity and marks a watershed moment for India’s pharmaceutical industry, the company’s founder chairman Habil Khorakiwala told TOI on Monday.
Zaynich, a combination of cefepime and zidebactam, is the first novel drug discovered and developed in India to secure USFDA approval, with peak sales estimated at over $1.5 billion, he said.
====
Indian Pharma companies are moving up the value chain.
